2:05 PM
Jan 09, 2018
 |  BC Innovations  |  Distillery Therapeutics

Infectious disease


Cell culture and mouse studies suggest inhibiting Candida MIR1 could help treat azole-resistant oropharyngeal candidiasis. In azole-resistant strains of C. albicans isolated from an HIV-infected patient and in...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$18 USD
More Info >